Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase

Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase
Ebos CEO John Cullity doesn't want to pre-empt regulators. (Image: supplied)
Jenny Ruth
Ebos Group's purchase of the LifeHealthcare business is unlikely to have trouble clearing competition watchdogs on either side of the Tasman since its existing medical devices business is quite small.Ebos bought the LMT and National Surgical businesses in late 2019 for A$34 million compared with the LifeHealthcare purchase price of A$1.17 billion.In August last year, it also announced the purchase of Pioneer Medical, a New Zealand-based importer and distributor of spine and major joint implants and associated surgical technologies.Ebos didn...

More Infrastructure

Our man in Argentina
Policy

Our man in Argentina

What happens when a pescatarian goes to the home of beef?

Oliver Lewis 14 Jan 2025
Fast-track panels to be set up from Feb 7
Policy

Fast-track panels to be set up from Feb 7

Application cost details expected in coming weeks. 

Oliver Lewis 10 Jan 2025
Rail tunnel important for coal exports to reopen
Infrastructure

Rail tunnel important for coal exports to reopen

Miner Bathurst Resources suffered a financial hit from the West Coast tunnel closure.

Oliver Lewis 08 Jan 2025
Infratil $480m injection prevents CDC devaluation
Infrastructure

Infratil $480m injection prevents CDC devaluation

The value of Infratil's holding has grown tenfold since acquisition. 

Gregor Thompson 07 Jan 2025